Developer docs
API playgroundTry for free, no card

Search company profiles

PB Leiner

Full company profile

uuid0007b7n

Namestring
PB Leiner
Legal namestring
Tessenderlo Group NV
Websiteurl
pbleiner.com
Company typeenum
Private
Founded yearint
1900
Descriptiontext

PB Leiner is a global B2B manufacturer of gelatin and collagen peptide ingredients headquartered in Vilvoorde, Belgium, operating as a division of Tessenderlo Group NV (Euronext: TESB). The company produces bovine, porcine, and fish-sourced gelatin and bioactive collagen peptides via controlled enzymatic hydrolysis, and operates manufacturing facilities across four continents (Belgium, Germany, USA, Argentina, Brazil, China). Its product portfolio is organized under four brands: SOLUGEL® collagen peptides for health, nutrition, and beauty-from-within applications; gelwoRx™ pharmaceutical-grade gelatin for capsules, medical devices, and biomedical uses; TEXTURA™ food gelatin for confectionery, dairy, bakery, and culinary applications; and Claro™ bio-inks for 3D tissue engineering. The company also produces functional lipids, proteins, and dicalcium phosphate for animal nutrition, pet food, and fertilizers.

The business model is direct enterprise B2B ingredient supply, with quote-based pricing on bulk commercial quantities sold to food, pharmaceutical, nutraceutical, and technical application manufacturers. Go-to-market combines dedicated regional sales teams (EMEA, North America, South America, Asia, Oceania), active technical and application support, co-innovation with customers, and consistent presence at industry trade events (Vitafoods, SupplySide, Food Ingredients Europe, FCE Pharma). Differentiation rests on 150 years of gelatin heritage, ownership of cold-soluble gelatin technology, multi-source raw material capability, regulatory compliance (EP/JP/USP pharmacopoeia standards, Kosher, Halal, GRAS), and a clinical evidence portfolio including Florida State University studies on joint health and healthy aging.

PB Leiner serves three primary end markets — Health & Nutrition, Pharma & Bioscience, and Food Solutions — alongside secondary segments in pet food/feed/fertilizers, technical applications, and bioprinting. The customer base comprises manufacturers integrating gelatin and collagen ingredients into formulations (no public logos available). Strategic posture in recent years has emphasized geographic and product expansion through joint ventures: a marine collagen joint venture with Hainan Xiangtai Group (China, 2023) and a Brazilian joint venture (2023), alongside product launches across the gelwoRx, SOLUGEL, and TEXTURA ranges. A 2026 market intelligence report indicates Darling Ingredients is acquiring over 50% control of the business, which would represent a significant ownership change to be confirmed.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersVilvoorde, Belgium
HQ citystring
Vilvoorde
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
gelatin manufacturing, collagen peptides, pharmaceutical gelatin, food texturizing solutions, bioprinting bio-inks
Industry4 codes
1Gelatin & Animal-Derived Hydrocolloids (Gelatin, Collagen, Isinglass)
CodeAFAJAMAGPrimaryYes
2Gelatin & Collagen Hydrolysates (Animal-Based Gelling Agents)
CodeAFAJABADPrimaryNo
3Animal-Derived Protein Ingredients (Egg, Collagen/Gelatin, Blood/Plasma Proteins)
CodeAFAJAHABPrimaryNo
4Protein Hydrolysates & Peptides (Enzymatic Hydrolysates, Bioactive Peptides)
CodeAFAJAHAIPrimaryNo
NAICS code1 code
  • Rendering and Meat Byproduct Processing311613
SIC code2 codes
  • Miscellaneous Food Preparations & Kindred Products2090
  • Medicinal Chemicals & Botanical Products2833
Product category
Gelatin and Collagen Ingredients
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1B2B Ingredient Sales
TypeHardware Sales
Description

PB Leiner operates as a B2B ingredient manufacturer and supplier, selling gelatin and collagen peptide ingredients to food, pharmaceutical, health nutrition, and technical application manufacturers worldwide. Products are sold in bulk quantities to enterprise customers who incorporate them into their formulations.

pbleiner.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1SOLUGEL®
Description

Collagen peptides brand offering bioactive peptides for health and nutrition applications including joint health, skin beauty, and sports nutrition.

pbleiner.com
+3 more records
Core offering1 text field

PB Leiner is a global B2B manufacturer of high-quality gelatin and collagen peptide ingredients, supplying food, pharmaceutical, health and nutrition, pet food, technical, and biomedical customers worldwide. The portfolio spans bioactive collagen peptides (SOLUGEL), pharmaceutical-grade gelatin (gelwoRx), food texturizing gelatin (TEXTURA), 3D bioprinting bio-inks (Claro), and functional lipids, proteins, and minerals derived from its gelatin production chain.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 93% of middle-aged adults globally are concerned about joint health, and 2 out of 3 experience moderate to severe joint pain
+3 more records
Product overview1 text field

PB Leiner is a global manufacturer of gelatin and collagen solutions serving food, pharmaceutical, health & nutrition, and technical application markets. The company operates under Tessenderlo Group and offers a multi-product portfolio organized into distinct brand lines: SOLUGEL® collagen peptides for health & nutrition applications (joint health, skin beauty, muscle recovery); gelwoRx™ pharmaceutical gelatin for oral dosage forms and medical devices; TEXTURA™ food-grade gelatin for texturizing applications; and Claro™ bio-inks for 3D bioprinting. Additionally, the company produces functional ingredients including dicalcium phosphate, proteins, and lipids for animal nutrition, pet food, fertilizers, and industrial applications. Production facilities span four continents with global technical and sales support.

Product and service1 record
1SOLUGEL Collagen Peptides
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Hainan Xiangtai Group
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-03-01
Description

Joint venture established in March 2023 with Hainan Xiangtai Group to produce and commercialize premium fish collagen peptides in China. The joint venture leverages PB Leiner's technology and Hainan Xiangtai's local expertise and sourcing capabilities. Production commenced in Q4 2022 with production facility inaugurated in March 2023 on Hainan Island, China.

pbleiner.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-03-01
Description

PB Leiner is a division of Tessenderlo Group (Euronext: TESB), a global industrial group focused on agriculture, bio-residual valorization, machinery, mechanical engineering, electronics, energy, and water management solutions. Tessenderlo Group provides corporate governance, strategic direction, and shared services including legal, finance, and sustainability programs.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Regemat 3D, a biotech company pioneer in design and development of customized 3D bioprinters and bioreactors for regenerative medicine research, distributes Claro's BG800 bio-ink developed for extrusion-based bioprinters.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

GELITA is one of the world's leading manufacturers of gelatin and collagen peptides, with a global production footprint. It directly competes with PB Leiner across food gelatin, pharma gelatin, and bioactive collagen peptides for nutraceutical applications.

TypeDirect peer
Description

Rousselot, owned by Darling Ingredients, is the largest global gelatin producer with a strong collagen peptide portfolio (Peptan). It is PB Leiner's primary direct competitor and is set to become a sister brand under the same parent following Darling's majority acquisition of PB Leiner.

TypeDirect peer
Description

Nitta Gelatin is a Japanese manufacturer of gelatin, collagen peptides, and related bioproducts with operations across Asia and North America. It competes head-to-head with PB Leiner in pharma-grade gelatin and Asian collagen peptide markets.

TypeDirect peer
Description

Weishardt is a European manufacturer of gelatin and collagen peptides serving food, nutraceutical, and cosmetics markets. Comparable to PB Leiner's mid-sized specialty gelatin and collagen peptide operations with emphasis on European customers.

5Italgelatine
TypeDirect peer
Description

Italgelatine is an Italian producer of gelatin and collagen hydrolysates for food, pharma, and nutrition applications. Directly comparable to PB Leiner's food gelatin (TEXTURA) and lower-tier collagen peptide lines serving European and global B2B customers.

TypeEmerging player
Description

Jellatech is a cell-based biotechnology company producing animal-free gelatin via precision fermentation. While not yet at PB Leiner's scale, it represents an emerging alternative to animal-derived gelatin in food, pharma, and cosmetics, with potential long-term competitive overlap.

TypeBroad incumbent
Description

Darling Ingredients is a global rendering and specialty ingredients leader, owner of Rousselot and now majority acquirer of PB Leiner. Operates broadly in collagen, gelatin, and animal-derived ingredients across food, pet food, and bioenergy end markets, making it both a parent and broad incumbent peer.

TypeBroad incumbent
Description

Cargill is a global agribusiness and food ingredient major with a protein and hydrocolloid portfolio that overlaps with PB Leiner's food gelatin and collagen peptide offerings. Operates at much larger scale and broader scope, including competing animal nutrition offerings.

TypeDirect peer
Description

Bioiberica is a Spanish life sciences company producing collagen peptides, heparin, and other bioactive ingredients for human and animal health. Directly comparable to PB Leiner's SOLUGEL collagen peptide business serving nutraceutical and joint health end markets.

TypeEmerging player
Description

Modern Meadow is a biotech company developing fermentation-derived collagen and other protein materials for beauty and apparel. As an emerging bioalternative to animal collagen, it represents a long-term competitive adjacency to PB Leiner's collagen peptide business.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PB Leiner

Gelatin and Collagen Ingredientspbleiner.com

What PB Leiner does

PB Leiner is a global B2B manufacturer of gelatin and collagen peptide ingredients headquartered in Vilvoorde, Belgium, operating as a division of Tessenderlo Group NV (Euronext: TESB). The company produces bovine, porcine, and fish-sourced gelatin and bioactive collagen peptides via controlled enzymatic hydrolysis, and operates manufacturing facilities across four continents (Belgium, Germany, USA, Argentina, Brazil, China). Its product portfolio is organized under four brands: SOLUGEL® collagen peptides for health, nutrition, and beauty-from-within applications; gelwoRx™ pharmaceutical-grade gelatin for capsules, medical devices, and biomedical uses; TEXTURA™ food gelatin for confectionery, dairy, bakery, and culinary applications; and Claro™ bio-inks for 3D tissue engineering. The company also produces functional lipids, proteins, and dicalcium phosphate for animal nutrition, pet food, and fertilizers.

The business model is direct enterprise B2B ingredient supply, with quote-based pricing on bulk commercial quantities sold to food, pharmaceutical, nutraceutical, and technical application manufacturers. Go-to-market combines dedicated regional sales teams (EMEA, North America, South America, Asia, Oceania), active technical and application support, co-innovation with customers, and consistent presence at industry trade events (Vitafoods, SupplySide, Food Ingredients Europe, FCE Pharma). Differentiation rests on 150 years of gelatin heritage, ownership of cold-soluble gelatin technology, multi-source raw material capability, regulatory compliance (EP/JP/USP pharmacopoeia standards, Kosher, Halal, GRAS), and a clinical evidence portfolio including Florida State University studies on joint health and healthy aging.

PB Leiner serves three primary end markets — Health & Nutrition, Pharma & Bioscience, and Food Solutions — alongside secondary segments in pet food/feed/fertilizers, technical applications, and bioprinting. The customer base comprises manufacturers integrating gelatin and collagen ingredients into formulations (no public logos available). Strategic posture in recent years has emphasized geographic and product expansion through joint ventures: a marine collagen joint venture with Hainan Xiangtai Group (China, 2023) and a Brazilian joint venture (2023), alongside product launches across the gelwoRx, SOLUGEL, and TEXTURA ranges. A 2026 market intelligence report indicates Darling Ingredients is acquiring over 50% control of the business, which would represent a significant ownership change to be confirmed.

PB Leiner firmographics

Firmographics
Name
PB Leiner
Legal name
Tessenderlo Group NV
Website
https://pbleiner.com
Company type
Private
Founded year
1900
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

PB Leiner industry classification

Industry
Product category
Gelatin and Collagen Ingredients
NAICS
Rendering and Meat Byproduct Processing (311613)
SIC
Miscellaneous Food Preparations & Kindred Products (2090), Medicinal Chemicals & Botanical Products (2833)
akta.pro primary industry
Gelatin & Animal-Derived Hydrocolloids (Gelatin, Collagen, Isinglass) (AFAJAMAG)
akta.pro secondary industries
Gelatin & Collagen Hydrolysates (Animal-Based Gelling Agents) (AFAJABAD), Animal-Derived Protein Ingredients (Egg, Collagen/Gelatin, Blood/Plasma Proteins) (AFAJAHAB), Protein Hydrolysates & Peptides (Enzymatic Hydrolysates, Bioactive Peptides) (AFAJAHAI)

Keywords

  • Gelatin manufacturing
  • Collagen peptides
  • Pharmaceutical gelatin
  • Food texturizing solutions
  • Bioprinting bio-inks

Where PB Leiner is headquartered

Location

Headquarters

HQ city
Vilvoorde
HQ country
Belgium
HQ region
Europe

Offices8 records

Markets served

PB Leiner business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. B2B Ingredient Sales: PB Leiner operates as a B2B ingredient manufacturer and supplier, selling gelatin and collagen peptide ingredients to food, pharmaceutical, health nutrition, and technical application manufacturers worldwide. Products are sold in bulk quantities to enterprise customers who incorporate them into their formulations.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

PB Leiner product offering

Product offering

Core offering

PB Leiner is a global B2B manufacturer of high-quality gelatin and collagen peptide ingredients, supplying food, pharmaceutical, health and nutrition, pet food, technical, and biomedical customers worldwide. The portfolio spans bioactive collagen peptides (SOLUGEL), pharmaceutical-grade gelatin (gelwoRx), food texturizing gelatin (TEXTURA), 3D bioprinting bio-inks (Claro), and functional lipids, proteins, and minerals derived from its gelatin production chain.

Product overview

PB Leiner is a global manufacturer of gelatin and collagen solutions serving food, pharmaceutical, health & nutrition, and technical application markets. The company operates under Tessenderlo Group and offers a multi-product portfolio organized into distinct brand lines: SOLUGEL® collagen peptides for health & nutrition applications (joint health, skin beauty, muscle recovery); gelwoRx™ pharmaceutical gelatin for oral dosage forms and medical devices; TEXTURA™ food-grade gelatin for texturizing applications; and Claro™ bio-inks for 3D bioprinting. Additionally, the company produces functional ingredients including dicalcium phosphate, proteins, and lipids for animal nutrition, pet food, fertilizers, and industrial applications. Production facilities span four continents with global technical and sales support.

Differentiator

Problem solved

Functional benefit

Brands

  • SOLUGEL®: Collagen peptides brand offering bioactive peptides for health and nutrition applications including joint health, skin beauty, and sports nutrition.
  • gelwoRx™
  • TEXTURA™
  • Claro™

Products and services

  • SOLUGEL Collagen Peptides

Quantifiable outcome

  • 93% of middle-aged adults globally are concerned about joint health, and 2 out of 3 experience moderate to severe joint pain
  • +3 more outcomes

Companies that use PB Leiner

Customer profile

Segments6 records

Ideal customer profiles5 records

PB Leiner technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

PB Leiner partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Hainan Xiangtai GroupcoreStrategic or Co-development Partner · 1 March 2023Joint venture established in March 2023 with Hainan Xiangtai Group to produce and commercialize premium fish collagen peptides in China. The joint venture leverages PB Leiner's technology and Hainan Xiangtai's local expertise and sourcing capabilities. Production commenced in Q4 2022 with production facility inaugurated in March 2023 on Hainan Island, China.
  • Tessenderlo GroupcoreStrategic or Co-development Partner · 1 March 2023PB Leiner is a division of Tessenderlo Group (Euronext: TESB), a global industrial group focused on agriculture, bio-residual valorization, machinery, mechanical engineering, electronics, energy, and water management solutions. Tessenderlo Group provides corporate governance, strategic direction, and shared services including legal, finance, and sustainability programs.
  • Regemat 3DminorChannel Partner/ Reseller/ DistributorRegemat 3D, a biotech company pioneer in design and development of customized 3D bioprinters and bioreactors for regenerative medicine research, distributes Claro's BG800 bio-ink developed for extrusion-based bioprinters.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

PB Leiner competitors and assessment

Company assessment

Direct peers

  • GELITA: GELITA is one of the world's leading manufacturers of gelatin and collagen peptides, with a global production footprint. It directly competes with PB Leiner across food gelatin, pharma gelatin, and bioactive collagen peptides for nutraceutical applications.
  • Rousselot: Rousselot, owned by Darling Ingredients, is the largest global gelatin producer with a strong collagen peptide portfolio (Peptan). It is PB Leiner's primary direct competitor and is set to become a sister brand under the same parent following Darling's majority acquisition of PB Leiner.
  • Nitta Gelatin: Nitta Gelatin is a Japanese manufacturer of gelatin, collagen peptides, and related bioproducts with operations across Asia and North America. It competes head-to-head with PB Leiner in pharma-grade gelatin and Asian collagen peptide markets.
  • Weishardt (Weishärdt Group): Weishardt is a European manufacturer of gelatin and collagen peptides serving food, nutraceutical, and cosmetics markets. Comparable to PB Leiner's mid-sized specialty gelatin and collagen peptide operations with emphasis on European customers.
  • Italgelatine: Italgelatine is an Italian producer of gelatin and collagen hydrolysates for food, pharma, and nutrition applications. Directly comparable to PB Leiner's food gelatin (TEXTURA) and lower-tier collagen peptide lines serving European and global B2B customers.
  • Bioiberica: Bioiberica is a Spanish life sciences company producing collagen peptides, heparin, and other bioactive ingredients for human and animal health. Directly comparable to PB Leiner's SOLUGEL collagen peptide business serving nutraceutical and joint health end markets.

Emerging players

  • Jellatech: Jellatech is a cell-based biotechnology company producing animal-free gelatin via precision fermentation. While not yet at PB Leiner's scale, it represents an emerging alternative to animal-derived gelatin in food, pharma, and cosmetics, with potential long-term competitive overlap.
  • Modern Meadow: Modern Meadow is a biotech company developing fermentation-derived collagen and other protein materials for beauty and apparel. As an emerging bioalternative to animal collagen, it represents a long-term competitive adjacency to PB Leiner's collagen peptide business.

Broad incumbents

  • Darling Ingredients: Darling Ingredients is a global rendering and specialty ingredients leader, owner of Rousselot and now majority acquirer of PB Leiner. Operates broadly in collagen, gelatin, and animal-derived ingredients across food, pet food, and bioenergy end markets, making it both a parent and broad incumbent peer.
  • Cargill: Cargill is a global agribusiness and food ingredient major with a protein and hydrocolloid portfolio that overlaps with PB Leiner's food gelatin and collagen peptide offerings. Operates at much larger scale and broader scope, including competing animal nutrition offerings.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

PB Leiner social profiles

Digital presence

PB Leiner compliance and trust

Trust signal

Compliance5 records

PB Leiner financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PB Leiner leadership team

Management profile

Number of profiles

Profiles5 records

PB Leiner subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

PB Leiner funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PB Leiner M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PB Leiner

What does PB Leiner do?

PB Leiner is a global B2B manufacturer of high-quality gelatin and collagen peptide ingredients, supplying food, pharmaceutical, health and nutrition, pet food, technical, and biomedical customers worldwide. The portfolio spans bioactive collagen peptides (SOLUGEL), pharmaceutical-grade gelatin (gelwoRx), food texturizing gelatin (TEXTURA), 3D bioprinting bio-inks (Claro), and functional lipids, proteins, and minerals derived from its gelatin production chain.

Is PB Leiner a public or private company?

PB Leiner is a private company. It is classified as corporate owned and is currently operating.

When was PB Leiner founded?

PB Leiner was founded in 1900. It employs 1,001 to 5,000 people.

Where is PB Leiner based?

PB Leiner is headquartered in Vilvoorde, Belgium, in the Europe region.

How does PB Leiner make money?

One revenue line is on record: B2B Ingredient Sales.

Who are PB Leiner's main competitors?

Direct peers on record are GELITA, Rousselot, Nitta Gelatin, Weishardt (Weishärdt Group), Italgelatine and Bioiberica. Emerging players are Jellatech and Modern Meadow. Broad incumbents are Darling Ingredients and Cargill.

Does PB Leiner have an API?

No public API is recorded for PB Leiner.

What industry is PB Leiner in?

PB Leiner's product category is Gelatin and Collagen Ingredients. Its primary akta.pro industry code is AFAJAMAG, Gelatin & Animal-Derived Hydrocolloids (Gelatin, Collagen, Isinglass), with a secondary code of AFAJABAD, Gelatin & Collagen Hydrolysates (Animal-Based Gelling Agents). Its NAICS code is 311613 and its SIC code is 2090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comCosmetic Ingredients Market is expected to Hit US$ 55.95 billion by 2032 | Major Companies - BASF SE, Croda International Plc, Evonik Industries AG, Clariant AG, Dow Chemical CompanyDataM Intelligence released a market research report projecting the global Cosmetic Ingredients Market will grow from US$ 35.45 billion in 2024 to US$ 55.95 billion by 2032, representing a CAGR of 5.87%. The report highlights three notable transactions in 2026: Darling Ingredients acquiring over 50% control of PB Leiner for gelatin and collagen peptide ingredients, WACKER Chemie AG partnering with Amyris for bio-based cosmetic ingredients, and IMCD completing the acquisition of South Korea-based distributor Dong Yang FT Corp.Market Data ForecastEurope Collagen Supplement Market Size, Share & Growth, 2033The Europe collagen supplement market was valued at USD 1.80 billion in 2024 and is projected to reach USD 3.84 billion by 2033, growing at a CAGR of 8.76% during the forecast period. Market growth is driven by an aging population, rising prevalence of joint and skin conditions, and increasing consumer preference for preventive wellness and beauty-from-within supplements. Key market leaders profiled include GELITA AG, Naticol (Weishardt Group), Rousselot (Darling Ingredients), PB Leiner (Tessenderlo Group), Helsinn Healthcare, Nestlé S.A., Bayer AG, and DSM-Firmenich AG.MarketsandMarketsCollagen Market Size, Trends, Growth Forecast 2025â2030 | Global Industry AnalysisThe global collagen market, valued at USD 5.1 billion in 2023, is projected to reach USD 7.4 billion by 2030 with a CAGR of 5.3%, driven by rising health awareness and expanding applications in nutraceuticals and cosmetics. A notable strategic development involves D&D Participações Societárias partnering with PB Leiner through a joint venture to develop sustainable gelatin products using combined technological and processing expertise. Market growth is further supported by the 'beauty-from-within' trend and advancements in extraction technologies for marine and plant-based alternatives.Market Research & Business IntelligenceUK Collagen Peptide Market Size, Trends & Growth 2025-2035The UK collagen peptide market is projected to grow from USD 50.5 million in 2025 to USD 81.9 million by 2035, representing a compound annual growth rate of 5.0% over the forecast period. Key growth drivers include rising demand for nutritional supplements, functional food and beverages, cosmetics, and sports nutrition, alongside innovations in marine and plant-based collagen alternatives. The market features several recent developments including Rousselot's £30 million production facility in Wales, PB Leiner's £45 million acquisition of NaturePep, and new product launches from Marine Collagen UK, Collagen Solutions, and Peptan UK.PR NewswireGelatin Market worth $5.6 billion by 2029 - Exclusive Report by MarketsandMarkets™The global gelatin market is projected to grow from USD 4.0 billion in 2024 to USD 5.6 billion by 2029, registering a compound annual growth rate of 6.9%, according to a market report by MarketsandMarkets. Key growth drivers include rising consumer health consciousness, expanding pharmaceutical applications such as capsules and surgical sponges, and the bovine segment accounting for a significant market share, with companies like JBS S.A. investing USD 77.45 million in a new production facility. North America is expected to hold a substantial market share, supported by major players including Darling Ingredients, GELITA AG, Nitta Gelatin, and PB Leiner.PR NewswireGlobal Collagen Markets Report 2022-2027: Opportunities in Functional Foods and Fortified Food, Medical Sector, & the Meat IndustryResearchAndMarkets.com has published a market research report on the global collagen market covering the period 2022–2027, with analysis across nutraceuticals, food and beverage, pharmaceutical, healthcare, cosmetics, and personal care sectors. The report provides market size estimations, five-year forecasts, regional breakdowns for North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, and includes competitive profiles of major vendors including Amicogen Inc., Gelnex, Junca Gelatines S.L., Nippi Collagen NA Inc., PB Leiner, Rousselot B.V., and Weishardt Group. Key growth drivers identified include rising demand for dietary supplements, sports nutrition, and cosmetic products, while restraints include the expanding vegan/vegetarian population and concerns about disease transmission.PR NewswireWorldwide Hydrolyzed Collagen Industry to 2027 - Rising Application of Hydrolyzed Collagen in Cosmetic and Personal Care Products Presents OpportunitiesResearchAndMarkets published a global market forecast for hydrolyzed collagen, estimating the market will grow from US$810.59 million in 2019 to US$1,247.53 million by 2027 at a 5.53% CAGR, with Europe holding the largest market share followed by Asia Pacific. The report identifies rising application in cosmetic and personal care products and growth in the pharmaceutical industry as key opportunities, while noting that COVID-19 disruptions have negatively impacted supply chains, manufacturing, and transportation across the food and beverage sector. Major players identified include Gelita AG, Rousselot, Nitta Gelatin, Protein S.A., ConnOils LLC, Norland Products Inc., PB Leiner, Ewald-Gelatin GmbH, Titan Biotech Limited, and Viscofan BioEngineering.PR NewswireResearch and Markets - Global Gelatin Market 2017-2021: Increasing Demand from the Pharmaceutical Industry - Key Vendors are GELITA, Nitta-Gelatin PB Gelatins, Rousselot & WeishardtResearch and Markets announced the addition of its "Global Gelatin Market 2017-2021" report to its offerings, projecting a CAGR of 6.38% for the period. The analysis highlights growing demand for kosher and halal certified gelatin due to religious dietary restrictions, while noting that rising vegetarianism poses a challenge through increased demand for plant-based alternatives. Key vendors identified in the market include GELITA, Nitta-Gelatin, PB Gelatins, Rousselot, and Weishardt.